Title: Digital Pathology Image Analysis in Pharmaceutical Discovery and Development different uses, differe
1Digital Pathology / Image Analysis in
Pharmaceutical Discovery and Development-
different uses, different concerns
- Daniel Weinstock DVM PhD DACVP
- sanofi aventis U.S., Inc.
- Bridgewater, N.J. USA
2The Digital Image Revolution
- Histopathologic assessment (the traditional
method) - - glass slides and an optical
microscope - - subjective semi-quantitative
assessment by a pathologist with
peer review of results - New approach
- - digital image acquisition with
computer based image
handling and viewing - - pathologist driven analysis with
generation of objective
quantitative, data - (Why) is this such a good thing?
3Pathology Applications in a Pharmaceutical Company
- Discovery (Research)
- Target Validation
- High Content Screening (HCS)
- Animal models
- Proof of concept / proof of mechanism studies
- Development
- GLP toxicologic pathology
- Biomarker development / validation
- Investigational toxicologic pathology
4Image AnalysisWhat kinds of questions?
- Characterization of changes in cells / tissues
- what kinds of changes
- severity and distribution
- Frequency and distribution of a microscopic
feature - normal versus diseased
- treated versus untreated
- Challenges
- non-uniformity of samples
- Variations in sample source, handling and
staining - small sample numbers
- large sample numbers
- subtlety of change
- spectrum of change
5Digital Imaging and Image AnalysisApplications,
Concerns and Reasons for Use
- Repeated measures
- uniform analysis (application of algorithm)
- Quantitative analysis
- hard numbers for diverse scientists
(committee decisions) - Large sample numbers
- prevents drift
- Distance pathology / telepathology
- remote image sharing
- collaboration / consultation
- GLP principles image handling, storage and
archive
6Digital ImagesAcceptance by Pathologists
Ultimate goal replace glass slide evaluation
via microscope with digital image evaluation on
computer screens
These issues must be addressed to the
satisfaction of the primary users of the
technology. Very good progress to date, but
improvement possible.
- Quality
- images
- data
- Speed
- slide scanning
- image access, handling
- field of view, magnification change, etc
- Cost and benefit
- Integration
- Ease of use
7Image Analysis Practical Aspects
- Team approach needed
- fusion of engineering and biological skill sets
- statisticians needed for complex analytical
techniques - Criteria for evaluation
- modifiable algorithm until final parameters
established - Reiterative evaluation and modification of
algorithm required - Should be able to review results of each
modification - Repeated modification should yield incremental
improvements in discrimination - final application of unchangeable algorithm to
total image set - End point believable, repeatable, biologically
relevant results - e.g. recognition of a nucleus many
ways to do it
8Image Analysis How To
- Digital image files acquired and stored
- working algorithm applied
- 1st round results generated
- can apply to smaller representative image set
- evaluation of results and assessment of
discrimination - algorithm modification, data set exclusion
- Application of 2nd, 3rd, etc modified
algorithms - reiterative cycle of modification and data
assessment - Final data generation and analysis
- applied to total set of images
- final review of analyzed images for QA is
desirable
9Discovery versus Development
- Types of questions
- therapeutic effects (discovery) versus
toxicologic effects (development) - disease status, model and assay development
(discovery) - Types of tissues / experiments
- species differences
- Standard toxicology species (rat, dog, etc.)
versus mice (genetically modified, knock-outs,
knock-downs, etc.) and other species - group size constraints
- reagent concerns
- Clients (end user)
- regulatory oriented (development) versus diverse
scientific community (discovery) - GLP compliance
- essential in Development, not relevant in
Discovery - Investigational Toxicologic Pathology hybrid
between the two
10(No Transcript)
11Image Analysis Concerns Tissues
- Liver (example tissue)
- Multiple types of changes possible
- Variable combinations of changes separate,
intermixed, etc. - Range of severity of each type of change
- Necrosis
- Fibrosis
- Inflammation
- Bile duct proliferation
- others
- Normal features difficult to differentiate
- Red blood cells
- Sinusoids amount of space affected by degree of
exsanguination - Kupffer cell nuclei difficult to discern from
inflammatory cells
12Range of Changes in a Lesion
- Liver
- - necrosis
- Issues
- Red cells within area of necrosis
- Clear spaces within necrosis vs. sinusoids
- Pyknotic nuclei vs. Kupffer cell nuclei
13Range of Changes in a Lesion
- Liver
- - bile duct proliferation
- Issues
- Edge effect.
- Differentiation between bile ducts and
arterioles. - Relatively uncomplicated change in this field.
14Range of Changes in a Lesion
- Liver
- - bile duct proliferation
- - fibrosis
- - inflammation
- Issues
- Differentiation between bile ducts and
arterioles. - Complicated by fibrosis and inflammation.
- Discrimination between nuclei of inflammatory
cells and Kupffer cells
15Range of Changes in a Lesion
- Liver
- - bile duct proliferation
- - fibrosis
- - inflammation
- Issues
- Complex morphology of multiple changes in one
focus of interest. - Severity change varies by focus.
16Range of Changes in a Lesion
- Liver
- - necrosis
- - fibrosis
- - bile duct proliferation
- - inflammation
- Issues
- Similar issues as previous images, but now
complicated by multiple contiguous types of
changes per field.
17Range of Changes in a Lesion
- Liver
- - necrosis
- - bile duct proliferation
- Issues
- Multiple non contiguous changes.
- Bile duct proliferation uncomplicated.
- Necrosis complex morphology in area of change.
18Image Analysis How to and Multiple
interactions
- Whats needed?
- turn key library with many validated algorithms
- can be located distant or local
- useful as starting point for further
modification - tool box for modification
- should be local (desktop)
- should be user (pathologist / scientist)
friendly - easily modified with rapid, repeated application
to a test data set - format for easy review of results and assessment
of discriminations being made - data should be accessible for statistical
analysis - final results should be biologically relevant
19FAQs common concerns
- What must be done to validate an image analysis
algorithm? - What justifies the time and effort investment to
develop an image analysis algorithm? - How predictive is a 2 dimensional slice of a
tissue (histologic section) for quantification of
an effect on a organ? How much sampling is
required? What kind of sampling is required?
Are we making appropriate comparisons? - What is necessary to power the experiment
appropriately?
20Integration of Images and Data
- GLP or non-GLP
- Necessary to be able to associate images with
blocks, tissues, animal identification,
treatments, experiments, etc - source information, interface with LIMS
(Laboratory Information Management System) - cross reference to lab books
- Necessary to be able to associate images with
multiple analyses and results - cross reference in reports
- interface with document generation programs
- Storage and retrieval of images and data
IS/IT participation essential - searchable (on how many and what criteria?)
- image quality / integrity
- Compression, storage space and location
- storage of primary image, annotated images,
etc. - Trade off amount of annotation vs. ease of use
(data entry time) - potential for retrospective analysis
21Technical Needs
- Rapid, automated slide scanning
- Multiple formats
- brightfield
- fluorescence
- Rapid, seamless change between magnifications
- Depth perception, polarization?
- Volumetric determinations?
- Pathologist / scientist supervised computer self
learning for image analysis
22 Other applications
- Digital Imaging
- - Telepathology - sharing of digital images
- Image Analysis - cellular to whole animal
- - HCS (High Content Screen)
- - Transgenic mice with in vivo light emission
(e.g. luciferase)
23Large Scale High Content Screeninge.g.
Anti-mitotics
What is the relevant measurement? Discrimination
parameters based on experimental observations
(data) with appropriate controls is essential.
- Parameters are often not intuitive. -
Results must be biologically relevant to
mechanism of action. Morphology varies with time,
dose, staining and mechanism of
action. Sophisticated approach with complex
analysis (re-analysis) is needed.
24Image Analysis HCS special issues
- Large experiments
- up to 384 well plates
- very large screens, very large data sets
- Feature extractions what, how, etc
- Image compression current use and archive
- resources for data storage become important with
time - loss of image integrity with compression may be
an issue especially for retrospective
analysis - Data normalization
- inherent variations within an experiment
- Data mining multivariate analysis
- need for sophisticated statistical analysis
multiple possible methods - team approach essential
- final biological relevance is essential
25Whole animal in vivo Bioimaging
- Transgenic animal with luciferase reporter
- luciferase (enzyme) is produced in response to
specified gene expression - enzyme substrate given intravenously
- whole mouse is imaged for in vivo light emission
- tissue imaged ex vivo
- image analysis used to quantify gene expression
based on light emission
Journal of Molecular Endocrinology (2005) 35,
293-304
26Evolution of the Process
- Technology and applications are in infancy
- New, easier, less expensive technology required
for widespread acceptance and use - Current investigators will validate the
technology for traditional applications - Future investigators who evolve with the
technology will likely be ones to define new,
unorthodox, innovative applications
27Summarywhat a pathologist wants / needs
- Digital Images
- Quality images
- Rapid manipulations
- Integrated systems
- Easy to use
- Image analysis
- Quality data
- Pathologist / scientist driven
- Reiterative process for refinement of criteria
- Easy to use
- You cant always get what you want
- - Rolling Stones, Hot Rocks,
1964-1971
Consider the constraints of the individual
workplace.